webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

Mal-amido-PEG2-Val-Cit-PAB-PNP

  CAS No.: 2112738-13-1   Cat No.: BADC-01066   Purity: >98.0% 4.5  

Mal-amido-PEG2-Val-Cit-PAB-PNP is a maleimide-linked PEGylated peptide ADC linker designed for stable antibody conjugation and controlled enzymatic cleavage of payloads in targeted therapy.

Mal-amido-PEG2-Val-Cit-PAB-PNP

Structure of 2112738-13-1

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C39H50N8O14
Molecular Weight
854.86
Shipping
Room temperature, or blue ice upon request.
Shipping
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
4-((2S,5S)-19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-4,7,17-trioxo-2-(3-ureidopropyl)-10,13-dioxa-3,6,16-triazanonadecanamido)benzyl (4-nitrophenyl) carbonate
IUPAC Name
Canonical SMILES
CC(C)C(C(=O)NC(CCCNC(=O)N)C(=O)NC1=CC=C(C=C1)COC(=O)OC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)CCOCCOCCNC(=O)CCN3C(=O)C=CC3=O
InChI
InChI=1S/C39H50N8O14/c1-25(2)35(45-32(49)16-20-58-22-23-59-21-18-41-31(48)15-19-46-33(50)13-14-34(46)51)37(53)44-30(4-3-17-42-38(40)54)36(52)43-27-7-5-26(6-8-27)24-60-39(55)61-29-11-9-28(10-12-29)47(56)57/h5-14,25,30,35H,3-4,15-24H2,1-2H3,(H,41,48)(H,43,52)(H,44,53)(H,45,49)(H3,40,42,54)/t30-,35-/m0/s1
InChIKey
PAGAOQLHMRBQFV-QGRQJHSQSA-N
Solubility
10 mm in DMSO
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature, or blue ice upon request.
Storage
Store at -20 °C, keep in dry and avoid sunlight.

Mal-amido-PEG2-Val-Cit-PAB-PNP, a versatile linker molecule used in drug delivery and bioconjugation, plays a pivotal role in various applications.

Antibody-Drug Conjugates (ADCs): Mal-amido-PEG2-Val-Cit-PAB-PNP serves as a crucial link in the synthesis of antibody-drug conjugates. This linkage between a cytotoxic drug and an antibody ensures site-specific drug release at the tumor, minimizing systemic toxicity while maximizing therapeutic efficacy.

Controlled Drug Release: Enabling the design of advanced drug delivery systems, Mal-amido-PEG2-Val-Cit-PAB-PNP linkers provide a sophisticated approach to controlled drug release triggered by specific stimuli such as pH variations or enzymatic activity. The Val-Cit peptide sequence, susceptible to tissue-specific enzymes, allows for precise and controlled drug release at designated sites. This method enhances therapeutic efficacy while mitigating adverse effects, optimizing drug delivery for improved patient outcomes.

Pharmaceutical Research: A cornerstone of pharmaceutical research, this linker molecule facilitates exploration into the design and enhancement of drug delivery systems. Researchers leverage its flexibility to adjust properties by modifying PEG length or integrating additional functional groups, tailoring the linker for diverse therapeutic applications. This strategic customization enhances pharmacokinetic profiles and bolsters the stability of therapeutic agents, driving innovation in pharmaceutical sciences and advancing drug delivery technologies.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker/Peptide Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker/Hydrazone Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: BCN-exo-PEG3-maleimide | BCN-exo-PEG8-NHS | Ansamitocin P 3' | Mal-PEG2-Val-Cit-PABA | Mal-PEG8-Val-Cit-PAB-MMAE | BCN-PEG3-VC-PFP ester | PBD dimer | Calicheamicin | Mal-amido-PEG2-Val-Cit-PAB-PNP
Send Inquiry
Verification code
Inquiry Basket